跳至主要内容
临床试验/IRCT20170315033086N8
IRCT20170315033086N8已完成2 期

Efficacy of inflawell capsules containing Boswellic acids on behavioral and cognitive symptoms and DTI changes in patients with frontotemporal dementia

Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Behavioral variant of Frontotemporal dementia based on guideline: Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134
  • Language variant of Frontotemporal dementia based on guideline: Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006-1014

排除标准

  • Other specific diseases of the central nervous system such as Parkinson's, multifactorial dementia, anterior brain dementia, Huntington's disease, hydrocephalus, brain tumors confirmed by MRI, severe paralysis of the nerve of the supernuclear body, epilepsy, clots between layers of brain tissue, multiple sclerosis and other dementias
  • Taking NSAIDs and systemic corticosteroids for previous two months continuously
  • Severe cardiovascular disease, kidney and liver disorders
  • Psychiatric disorders include bipolar disorder and schizophrenia under medication
  • Drugs or alcohol abuse
  • Brain-related surgical interventions
  • head trauma and progressive degenerative motor disorder
  • Metabolic and systemic diseases

研究者

相似试验